Synowledge Announces 15 New Customer Wins Worldwide

LONDON — August 30, 2010 – Synowledge LLC, a market leader in drug safety and pharmacovigilance services and related IT solutions for life sciences organizations of all sized announced its largest customer win growth to-date. Synowledge signs 15 new customers in 2010 (including a fortune 100 company and a top 20 pharma company). These new accounts outline Synowledge’s accelerating growth in its customer base and revenues.

Synowledge’s proven ability to provide its customers with quality services is evident in this double digit customer account growth. Synowledge’s growth in customer wins was spurred by the expansion of its global customer base – as well as Synowledge’s excellent service to existing customers.

In the past one year, Synowledge has dramatically increased its customer base with a number of new customers, including a fortune 100 company and a top 20 pharma company across the globe. In addition, existing Synowledge customers continued to upgrade and expand their usage of Synowledge solutions. Synwoledge’s strategic direction and customer-focused approach continue to drive the company’s innovation and growth.

“Synowledge, backed by its strong expertise in drug safety, PV and IT solutions, continues to invest proactively in the strategic expansion of its solution suite. Our solutions continue to be chosen over those offered by some of the largest service providers in the industry,” said David Ingraham, Director, Marketing & Sales.

About Synowledge

Synowledge is a global provider of drug safety and pharmacovigilance services and related IT solutions to small, mid and large size pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet all our clients’ needs. With more than 15 years of industry experience, our core team members have worked with leading pharmaceutical, biotech, medical device and health provider organizations. We have our headquarters located in Stamford CT, USA and additional offices in Bangalore, India and the United Kingdom. For more information, please visit www.synowledge.com.

###

Synowledge Continues Global Expansion with New Offices in UK and USA

LONDON — August 30, 2010 – Synowledge LLC, the market leader in drug safety and pharmacovigilance services and related IT solutions for life sciences organizations announced its inauguration of two new offices in Brentford, UK and Columbus OH, USA as part of its ongoing global growth strategy. These two new offices will act as strategic development centers and will also provide support services to Synowledge’s expanding client-base in the US and UK markets. The office addresses are given below:

UK Office Address:

Synowledge UK Limited

1000 Great West Road

Brentford, TW8 9HH

United Kingdom

USA Office Address:

1900 Polaris Parkway, Suite 450

Columbus, Ohio

43240

The decision to establish these two new offices in the US and UK is a result of the significant customer wins Synowledge has experienced in 2010. The expertise of Synowledge’s professionals and their ability to work closely with its customers as a trusted partner have resulted in significant growth in customer base and enhanced level of interest in our solutions.

The USA and UK region is a key market for Synowledge, and we recognize how important these two new facilities are for both our existing business initiatives and future strategic campaigns in the region. In addition to meeting current challenges for Synwoledge’s strategic growth, these two facilities will allow Synowledge to deliver superior sales and support to our customers and to the growing prospect base in the regions.

“We have seen a growing need from our clients in these two regions. Strengthening our presence in key regions around the globe is among a number of current programs we have launched to improve our customer service and build stronger relationships with our customers around the world.” said David Ingraham, Director, Marketing & Sales, “Since embarking on its worldwide strategic expansion plan in 2006, Synowledge is committed to deliver on technology innovation by continually improving our ability to service our current and new clients’ needs.”

About Synowledge

Synowledge is a global provider of drug safety and pharmacovigilance services and related IT solutions to small, mid and large size pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet all our clients’ needs. With more than 15 years of industry experience, our core team members have worked with leading pharmaceutical, biotech, medical device and health provider organizations. We have our headquarters located in Stamford CT, USA and additional offices in Bangalore, India and the United Kingdom. For more information, please visit www.synowledge.com.

###